Sign in
4

Changes in Ownership

Bolt Biotherapeutics, Inc. Filed Acc 0001209191-21-008516

Options or other derivatives

  • Chief Executive Officer acquired 340,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Derivatives
Schatzman Randall C Chief Executive Officer 2021-02-04 Grant or award · Stock Option (Right to Buy) +340,000 340,000 D
Loading xslF345X03/doc4.xml…